Cargando…

Broken-Symmetry DFT Computations for the Reaction Pathway of IspH, an Iron–Sulfur Enzyme in Pathogenic Bacteria

[Image: see text] The recently discovered methylerythritol phosphate (MEP) pathway provides new targets for the development of antibacterial and antimalarial drugs. In the final step of the MEP pathway, the [4Fe–4S] IspH protein catalyzes the 2e(–)/2H(+) reductive dehydroxylation of (E)-4-hydroxy-3-...

Descripción completa

Detalles Bibliográficos
Autores principales: Blachly, Patrick G., Sandala, Gregory M., Giammona, Debra Ann, Bashford, Donald, McCammon, J. Andrew, Noodleman, Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568833/
https://www.ncbi.nlm.nih.gov/pubmed/26098647
http://dx.doi.org/10.1021/acs.inorgchem.5b00751
_version_ 1782389952639664128
author Blachly, Patrick G.
Sandala, Gregory M.
Giammona, Debra Ann
Bashford, Donald
McCammon, J. Andrew
Noodleman, Louis
author_facet Blachly, Patrick G.
Sandala, Gregory M.
Giammona, Debra Ann
Bashford, Donald
McCammon, J. Andrew
Noodleman, Louis
author_sort Blachly, Patrick G.
collection PubMed
description [Image: see text] The recently discovered methylerythritol phosphate (MEP) pathway provides new targets for the development of antibacterial and antimalarial drugs. In the final step of the MEP pathway, the [4Fe–4S] IspH protein catalyzes the 2e(–)/2H(+) reductive dehydroxylation of (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate (HMBPP) to afford the isoprenoid precursors isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP). Recent experiments have attempted to elucidate the IspH catalytic mechanism to drive inhibitor development. Two competing mechanisms have recently emerged, differentiated by their proposed HMBPP binding modes upon 1e(–) reduction of the [4Fe–4S] cluster: (1) a Birch reduction mechanism, in which HMBPP remains bound to the [4Fe–4S] cluster through its terminal C(4)–OH group (ROH-bound) until the −OH is cleaved as water; and (2) an organometallic mechanism, in which the C(4)–OH group rotates away from the [4Fe–4S] cluster, allowing the HMBPP olefin group to form a metallacycle complex with the apical iron (η(2)-bound). We perform broken-symmetry density functional theory computations to assess the energies and reduction potentials associated with the ROH- and η(2)-bound states implicated by these competing mechanisms. Reduction potentials obtained for ROH-bound states are more negative (−1.4 to −1.0 V) than what is typically expected of [4Fe–4S] ferredoxin proteins. Instead, we find that η(2)-bound states are lower in energy than ROH-bound states when the [4Fe–4S] cluster is 1e(–) reduced. Furthermore, η(2)-bound states can already be generated in the oxidized state, yielding reduction potentials of ca. −700 mV when electron addition occurs after rotation of the HMBPP C(4)–OH group. We demonstrate that such η(2)-bound states are kinetically accessible both when the IspH [4Fe–4S] cluster is oxidized and 1e(–) reduced. The energetically preferred pathway gives 1e(–) reduction of the cluster after substrate conformational change, generating the 1e(–) reduced intermediate proposed in the organometallic mechanism.
format Online
Article
Text
id pubmed-4568833
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-45688332016-06-22 Broken-Symmetry DFT Computations for the Reaction Pathway of IspH, an Iron–Sulfur Enzyme in Pathogenic Bacteria Blachly, Patrick G. Sandala, Gregory M. Giammona, Debra Ann Bashford, Donald McCammon, J. Andrew Noodleman, Louis Inorg Chem [Image: see text] The recently discovered methylerythritol phosphate (MEP) pathway provides new targets for the development of antibacterial and antimalarial drugs. In the final step of the MEP pathway, the [4Fe–4S] IspH protein catalyzes the 2e(–)/2H(+) reductive dehydroxylation of (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate (HMBPP) to afford the isoprenoid precursors isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP). Recent experiments have attempted to elucidate the IspH catalytic mechanism to drive inhibitor development. Two competing mechanisms have recently emerged, differentiated by their proposed HMBPP binding modes upon 1e(–) reduction of the [4Fe–4S] cluster: (1) a Birch reduction mechanism, in which HMBPP remains bound to the [4Fe–4S] cluster through its terminal C(4)–OH group (ROH-bound) until the −OH is cleaved as water; and (2) an organometallic mechanism, in which the C(4)–OH group rotates away from the [4Fe–4S] cluster, allowing the HMBPP olefin group to form a metallacycle complex with the apical iron (η(2)-bound). We perform broken-symmetry density functional theory computations to assess the energies and reduction potentials associated with the ROH- and η(2)-bound states implicated by these competing mechanisms. Reduction potentials obtained for ROH-bound states are more negative (−1.4 to −1.0 V) than what is typically expected of [4Fe–4S] ferredoxin proteins. Instead, we find that η(2)-bound states are lower in energy than ROH-bound states when the [4Fe–4S] cluster is 1e(–) reduced. Furthermore, η(2)-bound states can already be generated in the oxidized state, yielding reduction potentials of ca. −700 mV when electron addition occurs after rotation of the HMBPP C(4)–OH group. We demonstrate that such η(2)-bound states are kinetically accessible both when the IspH [4Fe–4S] cluster is oxidized and 1e(–) reduced. The energetically preferred pathway gives 1e(–) reduction of the cluster after substrate conformational change, generating the 1e(–) reduced intermediate proposed in the organometallic mechanism. American Chemical Society 2015-06-22 2015-07-06 /pmc/articles/PMC4568833/ /pubmed/26098647 http://dx.doi.org/10.1021/acs.inorgchem.5b00751 Text en Copyright © 2015 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Blachly, Patrick G.
Sandala, Gregory M.
Giammona, Debra Ann
Bashford, Donald
McCammon, J. Andrew
Noodleman, Louis
Broken-Symmetry DFT Computations for the Reaction Pathway of IspH, an Iron–Sulfur Enzyme in Pathogenic Bacteria
title Broken-Symmetry DFT Computations for the Reaction Pathway of IspH, an Iron–Sulfur Enzyme in Pathogenic Bacteria
title_full Broken-Symmetry DFT Computations for the Reaction Pathway of IspH, an Iron–Sulfur Enzyme in Pathogenic Bacteria
title_fullStr Broken-Symmetry DFT Computations for the Reaction Pathway of IspH, an Iron–Sulfur Enzyme in Pathogenic Bacteria
title_full_unstemmed Broken-Symmetry DFT Computations for the Reaction Pathway of IspH, an Iron–Sulfur Enzyme in Pathogenic Bacteria
title_short Broken-Symmetry DFT Computations for the Reaction Pathway of IspH, an Iron–Sulfur Enzyme in Pathogenic Bacteria
title_sort broken-symmetry dft computations for the reaction pathway of isph, an iron–sulfur enzyme in pathogenic bacteria
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568833/
https://www.ncbi.nlm.nih.gov/pubmed/26098647
http://dx.doi.org/10.1021/acs.inorgchem.5b00751
work_keys_str_mv AT blachlypatrickg brokensymmetrydftcomputationsforthereactionpathwayofisphanironsulfurenzymeinpathogenicbacteria
AT sandalagregorym brokensymmetrydftcomputationsforthereactionpathwayofisphanironsulfurenzymeinpathogenicbacteria
AT giammonadebraann brokensymmetrydftcomputationsforthereactionpathwayofisphanironsulfurenzymeinpathogenicbacteria
AT bashforddonald brokensymmetrydftcomputationsforthereactionpathwayofisphanironsulfurenzymeinpathogenicbacteria
AT mccammonjandrew brokensymmetrydftcomputationsforthereactionpathwayofisphanironsulfurenzymeinpathogenicbacteria
AT noodlemanlouis brokensymmetrydftcomputationsforthereactionpathwayofisphanironsulfurenzymeinpathogenicbacteria